Primary Sclerosing Cholangitis
What's New
Last Posted: Aug 19, 2024
- Obstructive sleep apnea and 19 gastrointestinal diseases: a Mendelian randomization study.
Weiheng Yan, et al. Frontiers in psychiatry 2024 0 1256116 - Only repeatedly elevated IgG4 levels in primary sclerosing cholangitis may distinguish a particular patient phenotype.
Sandra Kalthoff, et al. BMC gastroenterology 2024 0 (1) 248 - Autoimmune diseases and COPD risk: A Mendelian randomization study.
Xinlai Ma, et al. International immunopharmacology 2024 0 112791 - Causal effects of autoimmune diseases on temporomandibular disorders and the mediating pathways: a Mendelian randomization study.
Xin Chen, et al. Frontiers in immunology 2024 0 1390516 - New target-HMGCR inhibitors for the treatment of primary sclerosing cholangitis: A drug Mendelian randomization study.
Jie Zhou, et al. Open medicine (Warsaw, Poland) 2024 0 (1) 20240994 - Causality of metabolites and metabolic pathways on cholestatic liver diseases: a Mendelian randomization study.
Zhengxiao Wei, et al. Frontiers in medicine 2024 0 1395526 - Whole-exome sequencing reveals novel cancer genes and actionable targets in biliary tract cancers in primary sclerosing cholangitis.
Marit M Grimsrud, et al. Hepatology communications 2024 0 (7) - Causal relationship between primary sclerosing cholangitis and systemic lupus erythematosus: a bidirectional Mendelian randomization study.
Ziwen Pan, et al. European journal of medical research 2024 0 (1) 351 - Dissecting the causal role of immunophenotypes in primary sclerosing cholangitis risk: A Mendelian randomization study.
Jie Zhou, et al. Medicine 2024 0 (26) e38626 - Intergenic risk variant rs56258221 skews the fate of naive CD4 T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis.
Tobias Poch, et al. Cell reports. Medicine 2024 0 101620
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: